Skip Navigation

Cardiovascular Research 1998 38(2):395-404; doi:10.1016/S0008-6363(98)00011-X
© 1998 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Bou-Abboud, E.
Right arrow Articles by Nattel, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bou-Abboud, E.
Right arrow Articles by Nattel, S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1998, European Society of Cardiology

Molecular mechanisms of the reversal of imipramine-induced sodium channel blockade by alkalinization in human cardiac myocytes

Elias Bou-Abboudb and Stanley Nattela,b,c,*

aDepartment of Medicine, Institut de Cardiologie de Montréal and Université de Montréal, McGill University, Montreal, Quebec, Canada
bDepartment of Pharmacology, Université de Montréal, McGill University, Montreal, Quebec, Canada
cDepartment of Pharmacology and Therapeutics, McGill University, Montreal, Quebec, Canada

* Corresponding author. Research Center, Montreal Heart Institute, 5000 Bélanger Street East, Montreal, Quebec, Canada H1T 1C8. Tel.: +1 (514) 376 3330; Fax: +1 (514) 376 1355; E-mail: nattel@icm.umontreal.ca

Background: Alkalinizing agents reverse cardiotoxicity of a variety of sodium channel blockers, including tricyclic antidepressants, but their mechanisms of action are poorly understood. Purpose: To establish the mechanisms by which alkalinization diminishes the sodium channel blocking action of imipramine. Methods: The whole-cell voltage-clamp technique was used to measure INa during a variety of depolarizing pulse protocols in isolated human atrial myocytes, in the presence and absence of imipramine. A three-state model was used to analyze state-dependent INa block. Results: Imipramine (1 and 5 µM) strongly inhibited INa. Experimental data and piecewise exponential analysis suggested significant binding to both activated and inactivated states. Alkalosis antagonized imipramine-induced INa blockade by increasing the unbinding rate, with intracellular alkalosis being more effective than extracellular alkalosis. The dissociation constant (Kd) for the inactivated state was increased from 0.55 to 1.40 µM by extracellular alkalosis and to 2.51 µM by intracellular alkalosis. Along with the reversal of drug-induced shifts in the inactivation curve, these data indicate that alkalosis on either side of the membrane antagonized drug interactions with the inactivated state. On the other hand, only intracellular alkalosis antagonized activated state block, increasing the Kd from 0.67 µM to 2.18 µM, while extracellular alkalosis left the activated state Kd unaltered at 0.67 µM. Conclusions: Alkalinization antagonizes the INa-blocking action of imipramine by promoting unbinding from the receptor. Intracellular alkalosis has a particularly important effect related to the activated-state interaction. The lipid-soluble, uncharged moiety appears to be a critical determinant of imipramine's ability to dissociate from the Na+ channel receptor.

KEYWORDS Sodium channel; Cardiac arrhythmias; Local anesthetics; pH; Antiarrhythmic drugs


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
N. Lenkey, R. Karoly, J. P. Kiss, B. K. Szasz, E. S. Vizi, and A. Mike
The Mechanism of Activity-Dependent Sodium Channel Inhibition by the Antidepressants Fluoxetine and Desipramine
Mol. Pharmacol., December 1, 2006; 70(6): 2052 - 2063.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Part 4: Advanced Life Support
Circulation, November 29, 2005; 112(22_suppl): III-25 - III-54.
[Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Nau, M. Seaver, S.-Y. Wang, and G. K. Wang
Block of Human Heart hH1 Sodium Channels by Amitriptyline
J. Pharmacol. Exp. Ther., March 1, 2000; 292(3): 1015 - 1023.
[Abstract] [Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.